BACKGROUND: Individuals with an "at-risk mental state" (or "prodromal" symptoms) have a 20-40% chance of developing psychosis; however it is difficult to predict which of them will become ill on the basis of their clinical symptoms alone. We examined whether neurophysiological markers could help to identify those who are particularly vulnerable. METHOD: 35 cases meeting PACE criteria for the at-risk mental state (ARMS) and 57 controls performed an auditory oddball task whilst their electroencephalogram was recorded. The latency and amplitude of the P300 and N100 waves were compared between groups using linear regression. RESULTS: The P300 amplitude was significantly reduced in the ARMS group [8.6+/-6.4 microvolt] compared to controls [12.7+/-5.8 microvolt] (p<0.01). There were no group differences in P300 latency or in the amplitude and latency of the N100. Of the at-risk subjects that were followed up, seven (21%) developed psychosis. CONCLUSION: Reduction in the amplitude of the P300 is associated with an increased vulnerability to psychosis. Neurophysiological and other biological markers may be of use to predict clinical outcomes in populations at high risk.
BACKGROUND: Individuals with an "at-risk mental state" (or "prodromal" symptoms) have a 20-40% chance of developing psychosis; however it is difficult to predict which of them will become ill on the basis of their clinical symptoms alone. We examined whether neurophysiological markers could help to identify those who are particularly vulnerable. METHOD: 35 cases meeting PACE criteria for the at-risk mental state (ARMS) and 57 controls performed an auditory oddball task whilst their electroencephalogram was recorded. The latency and amplitude of the P300 and N100 waves were compared between groups using linear regression. RESULTS: The P300 amplitude was significantly reduced in the ARMS group [8.6+/-6.4 microvolt] compared to controls [12.7+/-5.8 microvolt] (p<0.01). There were no group differences in P300 latency or in the amplitude and latency of the N100. Of the at-risk subjects that were followed up, seven (21%) developed psychosis. CONCLUSION: Reduction in the amplitude of the P300 is associated with an increased vulnerability to psychosis. Neurophysiological and other biological markers may be of use to predict clinical outcomes in populations at high risk.
Authors: Wi Hoon Jung; June Sic Kim; Joon Hwan Jang; Jung-Seok Choi; Myung Hun Jung; Ji-Young Park; Ji Yeon Han; Chi-Hoon Choi; Do-Hyung Kang; Chun Kee Chung; Jun Soo Kwon Journal: Schizophr Bull Date: 2009-12-21 Impact factor: 9.306
Authors: Jürgen Kayser; Craig E Tenke; Christopher J Kroppmann; Daniel M Alschuler; Shiva Fekri; Shelly Ben-David; Cheryl M Corcoran; Gerard E Bruder Journal: Int J Psychophysiol Date: 2013-12-13 Impact factor: 2.997
Authors: Christoph U Correll; Marta Hauser; Andrea M Auther; Barbara A Cornblatt Journal: J Child Psychol Psychiatry Date: 2010-02-26 Impact factor: 8.982
Authors: Yingying Tang; Junjie Wang; Tianhong Zhang; Lihua Xu; Zhenying Qian; Huiru Cui; Xiaochen Tang; Huijun Li; Susan Whitfield-Gabrieli; Martha E Shenton; Larry J Seidman; Robert W McCarley; Matcheri S Keshavan; William S Stone; Jijun Wang; Margaret A Niznikiewicz Journal: Schizophr Res Date: 2019-02-25 Impact factor: 4.939
Authors: Holly K Hamilton; Veronica B Perez; Judith M Ford; Brian J Roach; Judith Jaeger; Daniel H Mathalon Journal: Schizophr Bull Date: 2018-04-06 Impact factor: 9.306
Authors: Steven J Luck; Daniel H Mathalon; Brian F O'Donnell; Matti S Hämäläinen; Kevin M Spencer; Daniel C Javitt; Peter J Uhlhaas Journal: Biol Psychiatry Date: 2010-12-15 Impact factor: 13.382